SCHEMBL4354240

SCHEMBL4354240

O=C(NCc1ccc(C(F)(F)F)cc1)N(S)c1ccc(F)c(F)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 2/20 0.43
HDAC1 Q13547 2/20 0.43
LSS P48449 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
MAPK14 Q16539 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NAMPT P43490 1/20 0.38
P2RX7 Q99572 2/20 0.37
OPRM1 P35372 1/20 0.37
OPRL1 P41146 1/20 0.37
EPHX2 P34913 1/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4348563 0.86 MAPK14 (0.44) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4347077 0.81 EPHX2 (0.45) MTORNPC1RAB9AP2RX7EPHX2
SCHEMBL4341863 0.81 HDAC3 (0.48) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4354458 0.81 MTOR (0.42) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4347497 0.80 MAPT (0.47) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4348897 0.80 MTOR (0.50) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4351483 0.79 MTOR (0.42) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4359745 0.78 TMPRSS4 (0.50) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4354019 0.76 HDAC1 (0.45) MTORHDAC1LSSHDAC3HDAC2
SCHEMBL4345514 0.75 MTOR (0.38) MTORHDAC1LSSHDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 MTOR 1379/4885HDAC1 750/4885LSS 730/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 MTOR 1296/4885HDAC1 288/4885LSS 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.